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The immediate outcome of the first 150 patients (Group 1) and the 
last 161 patients (Group 2) who underwent percutaneous mitral 
balloon valvuloplasty was compared. There was no difference 
between the two groups in age, gender, New York Heart Associ-
ation functional class, presence of calcification, atrial fibrillation, 
degree of mitral regurgitation, mean pulmonary artery pressure, 
left atrial pressure, cardiac output, pulmonary vascular resis-
tance, mitral valve gradient and mitral valve area. Fewer patients 
in Group 1 than Group 2 had an echocardiographic score :0;8 
(62% versus 69%, respectively, p = 0.02). The atrial septum was 
dilated with an 8 mm balloon in 74% of patients in Group 1 and 
with a 5 mm balloon in all patients in Group 2. 
Ratio of effective balloon dilating area to body surface area was 
larger in Group 1 than in Group 2 (4.05 ± 0.07 versus 3.7 ± 
0.03 cm2/m2, p = 0.0001). A good result (mitral valve area 
Since its introduction by Inoue et al. (1) in 1984, numerous 
investigators (2-5) have shown that percutaneous mitral 
valvuloplasty leads to good short- and intermediate-term 
results in patients with symptomatic mitral stenosis. In this 
study, by comparing the results of our early and late expe-
rience, we evaluated the impact of refinement of technique, 
improvement in equipment, increased operator experience 
and better patient selection on the immediate outcome and 
complications of percutaneous mitral valvuloplasty. 
Methods 
Study patients. Between August 1986 and September 
1989, 311 patients underwent percutaneous mitral valvulo-
plasty for symptomatic mitral stenosis at the Massachusetts 
General Hospital. The study was approved by the hospital's 
Institutional Human Research Review Committee. All pa-
tients signed informed consent forms. We classified our 
patients into two groups, according to the date of the 
procedure: 150 patients who underwent percutaneous mitral 
valvuloplasty between August 1986 and January 1988 formed 
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~1.5 cm2) was obtained in 77% and 75% in Groups 1 and 2, 
respectively (p = NS). After percutaneous mitral valvuloplasty, a 
~2 grade increase in mitral regurgitation was noted in 12% of 
Group 1 and 6% of Group 2 (p = 0.02) and a left to right shunt 
was detected in 22 % of Group 1 and 11 % of Group 2 (p = 
0.0001). There were three procedure-related deaths in Group 1, 
but none in Group 2. 
It is concluded that improvements in technique, patient selec-
tion and operator experience have decreased left to right shunting 
and the incidence of ~2+ increment in mitral regurgitation and 
have created a trend toward a lower mortality rate while main-
taining the high success rate of percutaneous mitral balloon 
valvuloplasty. 
(J Am Coll CardioI1991;17:1121-4) 
Group 1; 161 patients who underwent the procedure between 
February 1988 and September 1989 formed Group 2. There 
were 124 women and 26 men in Group 1 and 131 women and 
30 men in Group 2. The mean age in each group was 54 ± 1 
years. 
All patients underwent transthoracic two-dimensional 
and Doppler echocardiography and, when necessary, trans-
esophageal echocardiography. Percutaneous mitral valvulo-
plasty was not performed in patients who had definite or 
suspected left atrial thrombus. Patients with atrial fibrillation 
or a history of previous thromboembolic episodes were 
treated with warfarin for 2::3 months before undergoing 
valvuloplasty. 
Procedure. Two of us (P.C.B., I.F.P.) were operators in 
all of the percutaneous mitral valvuloplasty procedures using 
a previously described technique (6). Single balloon valvu-
loplasty was performed in 20 patients in Group 1; in the 
remaining 130 patients in Group 1 and in all 161 patients in 
Group 2, the double balloon technique was employed. Since 
February 1988, balloon sizes have been selected according 
to the patient's body surface area, as described previously 
(7). An 8 mm balloon dilating catheter was used to dilate the 
atrial septum in 74% of Group 1 patients; a 5 mm balloon was 
used in the remaining 26% in Group 1 and in all Group 2 
patients. 
Right and left heart pressures, transmitral gradient, oxi-
metry and cardiac output measurements were performed 
before and immediately after the procedure. Cardiac output 
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Table 1. Baseline Clinical Characteristics in the Two 
Patient Groups 
NYHA functional class 
I 
II 
III 
IV 
Atrial fibrillation 
Calcification 
22 + mitral regurgitation 
Echocardiographic 
score >8 
Prior commissurotomy 
Group I 
(n = 150) 
No. (%) 
I (I) 
22 (15) 
92 (61) 
35 (23) 
67 (45) 
73 (49) 
13 (9) 
57 (38)* 
31 (21) 
*p = 0.02. NYHA = New York Heart Association. 
Group 2 
(n = 161) 
No. (%) 
0(0) 
56 (35) 
88 (55) 
16 (10) 
87 (54) 
59 (43) 
16 (II) 
46 (31)* 
37 (22) 
was measured by the thermodilution technique. However, 
when there was a ?7% step-up between the superior vena 
cava and the pulmonary artery oxygen saturations after 
valvuloplasty or tricuspid regurgitation was present, cardiac 
output was measured according to the Fick principle. Left to 
right shunt was calculated by the Fick method and consid-
ered significant when it was ?1.5: 1. Left ventriculography 
was performed in the right anterior oblique projection before 
and immediately after valvuloplasty. Severity of mitral re-
gurgitation was assessed according to the method of Sellers 
et al. (8). Procedure-related death was defined as in-hospital 
death directly or indirectly caused by mitral valvuloplasty. 
In-hospital death that was clearly due to unrelated causes 
was not considered to be a procedure-related death. 
Statistical analysis. Student's unpaired t test was used to 
compare continuous variables. Fisher's exact test was used 
to compare categorical variables. A p value <0.05 was 
considered significant. 
Results 
Baseline characteristics. There were no differences be-
tween the two groups in age, gender, New York Heart 
Association functional class before percutaneous mitral val-
vuloplasty, presence of atrial fibrillation, fluoroscopically 
visible mitral valve calcification and presence and degree of 
mitral regurgitation before valvuloplasty (Table I). Simi-
larly, there were no differences in baseline hemodynamic 
variables between the two groups (Table 2). 
The mean echocardiographic score for patients in Group 
1 was 8.1 ± 2.5 compared with 7.5 ± 1.9 in Group 2 (p = 
0.02) (9). The percent of patients with an echocardiographic 
score >8 was 38% in Group 1 and 31% in Group 2 (p = 0.02). 
Procedure. The effective balloon dilating area of the 
balloons used in the double balloon procedure was 7.14 ± 
0.06 and 6.2 ± 0.05 cm2 in Groups 1 and 2, respectively (p = 
0.0001). The ratio of effective balloon dilating area to body 
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Table 2. Hemodynamic Findings Before and After Percutaneous 
Mitral Valvuloplasty in the Two Patient Groups 
PAP (mm Hg) 
PVR (dynes·s·cm2) 
CO (liters/min) 
MVG (mm Hg) 
MVA (cm2) 
Group I 
(n = 150) 
Pre·PMV Post-PMV 
40 ± I 29 ± 1 
373 ± 32 290 ± 20 
4.0 ± 0.1 4.5 ± 0.1 
16 ± 0.5 6 ± 0.2 
0.9 ± 0.03 2.0 ± 0.1 
Group 2 
(n = 161) 
Pre-PMV Post-PM V 
36 ± 1 29 ± 9 
280 ± 20 259 ± 16 
3.8 ± 0.1 4.4 ± 0.1 
15 ± 0.5 5 ± 0.2 
0.9 ± 0.02 2.0 ± 0.1 
CO = cardiac output; MV A = mitral valve area; MVG = mitral valve 
gradient; PAP = mean pulmonary artery pressure; PMV = percutaneous 
mitral valvuloplasty; PVR = pulmonary vascular resistance. 
surface area was 4.05 ± 0.07 cm2/m2 in Group 1 and 3.7 ± 
0.03 cm2/m2 in Group 2 (p = 0.0001). 
Outcome. There were no significant differences in pulmo-
nary artery pressure, pulmonary vascular resistance, trans-
mitral gradient, cardiac output and calculated mitral valve 
area after percutaneous mitral valvuloplasty in Groups 1 and 
2 (Table 2). Grade 2 or greater increase in mitral regurgita-
tion after valvuloplasty occurred in 18 patients (12%) in 
Group 1 and 9 patients (6%) in Group 2 (p = 0.02) (Table 3). 
A left to right shunt detected by oximetry immediately 
after percutaneous mitral valvuloplasty was present in 33 
patients (22%) in Group 1 and 18 patients (11%) in Group 2 
(p = 0.001). In Group I, the left to right shunt was <2: 1 in 26 
patients and ?2: 1 in 7 patients. In Group 2, the left to right 
shunt was <2:1 in 16 patients and ?2:1 in 2 patients. 
There were five in-hospital deaths. One patient had un-
complicated and successful mitral valvuloplasty and died 
during percutaneous aortic valvuloplasty performed at a 
later date. One patient who had chronic renal failure and 
respiratory failure had uncomplicated and successful mitral 
valvuloplasty. He died because of his chronic illnesses after 
a long hospital stay. There were no procedure-related deaths 
in Group 2, but three in Group 1 (p = 0.1). Of these three 
patients, one was brought to the catheterization laboratory 
in cardiogenic shock for emergency percutaneous mitral 
valvuloplasty and died despite a technically successful and 
uncomplicated procedure. One patient died of tamponade 
and another died during emergency open heart surgery 
performed for cardiac tamponade and mitral valve replace-
Table 3. Complications of Percutaneous Mitral Valvuloplasty in 
the Two Patient Groups 
Group I Group 2 
(n = 150) (n = 161) 
No. (%) No. (%) p Value 
Death 3 (2) 0(0) 0.1 
22 grades increase in MR 18 (12) 9 (6) 0.02 
Left to right in atrial 33 (22) 18 (II) 0.0001 
shunt* 
*Shunt detected by oximetry. MR = mitral regurgitation. 
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ment. Four other patients had cardiac tamponade; three in 
Group 1 and one in Group 2 (p = NS). All were successfully 
treated by pericardiocentesis. 
In the subgroup of patients who had single balloon 
valvuloplasty, there was no procedure-related death, no 
2':2 + increase in the grade of mitral regurgitation and five left 
to right shunts after valvuloplasty. 
Discussion 
Patient selection. Echocardiographic scoring of the mitral 
valve, proper sizing of valvuloplasty balloons (using a 
smaller balloon for interatrial septum dilation) and increased 
operator experience have changed the outcome of percuta-
neous mitral valvuloplasty. In our recent experience, there 
was less mitral regurgitation, left to right shunting and 
procedure-related death after valvuloplasty. 
We believe that echocardiographic evaluation of the 
mitral valve plays a pivotal role in the selection of patients 
with mitral stenosis for percutaneous mitral valvuloplasty 
performed by the double balloon technique as described. 
Echocardiographic evaluation of the valvular and subvalvu-
lar structures of the mitral valve is the most powerful 
predictor of the outcome of percutaneous mitral valvulo-
plasty (9-11). Patients with high echocardiographic scores 
do not do as well as patients with lower echocardiographic 
scores in early or late outcome, just as the data from surgical 
series (12,13) support the importance of the valvular and 
subvalvular anatomy in the outcome of surgical mitral com-
missurotomy. Thus, by careful selection, patients in Group 2 
had a more favorable anatomy for valvuloplasty than did 
patients in Group 1. We did not use transesophageal echo-
cardiography routinely to evaluate patients for valvuloplasty 
unless there was a specific indication. However, further use 
of this technique may improve our understanding of mitral 
stenosis and detection of atrial thrombus and lead to even 
better patient selection. 
Mitral regurgitation. Although the mean mitral valve 
area after percutaneous mitral valvuloplasty is similar in our 
two groups, a significant increase in mitral regurgitation after 
valvuloplasty occurred more commonly in Group 1 patients. 
The reduction in the incidence of mitral regurgitation is 
probably due to better selection of balloon sizes. We have 
previously shown (7) that the effective balloon dilating area 
is an important determinant of mitral regurgitation after 
valvuloplasty and that the optimal ratio of effective balloon 
dilating area to body surface area is between 3.1 and 
4.0 cm2/m2 for any given patient. Balloon sizes were selected 
according to this principle in all patients in Group 2. Al-
though Abascal et al. (14) in their relatively small study 
concluded that valvular anatomy is not a predictor of an 
increase in mitral regurgitation after valvuloplasty, other 
investigators (5,15) have stressed the importance of valvular 
and subvalvular anatomy in this complication. In Group 2, 
selection of patients with a more favorable anatomy as well 
as selection of smaller balloon sizes might have played a role 
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in the reduction of the frequency and severity of mitral 
regurgitation after valvuloplasty. As previously reported by 
Roth et al. (7), the single balloon technique, used in a small 
subgroup of patients in our experience, appeared to lead to a 
lower incidence of 2':2+ mitral regurgitation after valvulo-
plasty but resulted in a smaller mitral valve area. 
Left to right intraatrial shunt. Significant left to right 
shunting was less frequent in our later experience. Casale et 
al. (16) found older age, low cardiac output, poor functional 
class, fluoroscopically visible mitral valve calcification and 
high echocardiographic score to be predictors of left to right 
shunting after percutaneous mitral valvuloplasty. Group 1 
and Group 2 were similar in terms of these characteristics, 
except for the echocardiographic score. However, technical 
factors also determine the incidence of shunting after valvu-
loplasty (17). In a recent report by Cequier et al. (18), a small 
mitral valve area after valvuloplasty was the strongest pre-
dictor of a left to right shunt after valVUloplasty. We had 
fewer patients with left to right shunting after valvuloplasty 
in Group 2, although the postvalvuloplasty mitral valve area 
was similar in the two groups. This highly significant differ-
ence is probably due to a combination of factors, namely, 
increased operator experience, smaller balloon size (5 mm) 
for atrial septum dilation and better patient selection 
(echocardiographic score). In the future, development of 
catheters with a lower profile will undoubtedly decrease the 
rate of left to right shunting after percutaneous mitral valvu-
loplasty. 
Mortality. Predictors of procedure-related death in per-
cutaneous mitral valvuloplasty are not well known, mainly 
because of the relatively low risk of the procedure and the 
small number of reported series. Some deaths were due to 
perforation of the left ventricular apex. Others were attrib-
uted to the patients' poor condition (5,19). We had no 
procedure-related death in Group 2 (versus 2% mortality rate 
in Group 1). The difference between the procedure-related 
deaths and incidence of cardiac tamponade was not statisti-
cally significant. Nevertheless, both of these complications 
were more frequent in Group 1. Despite our inability to 
document the factors that contribute to the tendency of 
decreased mortality and tamponade, we believe that opera-
tor experience and careful patient selection play important 
roles in this difference. To be an alternative to surgical mitral 
commissurotomy, percutaneous mitral valvuloplasty must 
be performed with a procedural mortality rate of approxi-
mately 1% (13). 
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